for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Humana Inc

HUM.N

Latest Trade

377.84USD

Change

-10.04(-2.59%)

Volume

407,204

Today's Range

375.60

 - 

391.19

52 Week Range

351.58

 - 

475.40

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Humana Inc Says On Jan 11, Co Entered Into Separate Accelerated Stock Repurchase Agreements

Jan 12 (Reuters) - Humana Inc <HUM.N>::HUMANA INC - ON JAN 11, CO ENTERED INTO SEPARATE ACCELERATED STOCK REPURCHASE AGREEMENTS.HUMANA - ASR AGREEMENTS TO REPURCHASE AN AGGREGATE OF $1.0 BILLION OF STOCK AS PART OF $3.0 BILLION REPURCHASE ANNOUNCED ON FEB. 18, 2021.

Humana Inc - Intends To Reaffirm Guidance Of About $23.67 In EPS, Or About $20.50 In Adjusted EPS, For Year Ending December 31, 2021

Jan 6 (Reuters) - Humana Inc <HUM.N>::HUMANA INC - INTENDS TO REAFFIRM GUIDANCE OF ABOUT $23.67 IN EPS, OR ABOUT $20.50 IN ADJUSTED EPS, FOR YEAR ENDING DECEMBER 31, 2021.HUMANA - NOW SEES NET MEMBERSHIP GROWTH ESTIMATE FOR INDIVIDUAL MEDICARE ADVANTAGE PRODUCTS FOR YEAR ENDED DEC. 31, 2022 OF 150,000-200,000 MEMBERS.HUMANA INC - CONTINUES TO EXPECT GROUP MEDICARE ADVANTAGE MEMBERSHIP TO BE GENERALLY FLAT FOR 2022.HUMANA INC - FOR PDP, THE COMPANY NOW ESTIMATES A NET MEMBERSHIP DECLINE OF APPROXIMATELY 125,000 MEMBERS FOR THE YEAR ENDED DECEMBER 31, 2022.HUMANA INC - CURRENTLY ANTICIPATES THAT COVID WILL BE NET NEUTRAL TO THE MEDICARE ADVANTAGE BUSINESS IN 2022.HUMANA INC - INTENDS TO REITERATE ITS 2022 ADJUSTED EPS GUIDANCE COMMENTARY, AS SHARED ON ITS THIRD QUARTER 2021 EARNINGS CALL.HUMANA INC - INITIAL 2022 ADJUSTED EPS GUIDANCE WILL INCLUDE EXPLICIT COVID RELATED HEADWIND THAT IT EXPECTS TO BE ABLE TO TOLERATE SHOULD IT EMERGE.

Humana Reports Q3 2021 Financial Results Revises Full Year 2021 EPS Financial Guidance

Nov 3 (Reuters) - Humana Inc <HUM.N>::HUMANA REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS; REVISES FULL YEAR 2021 EPS FINANCIAL GUIDANCE.SEES FY ADJUSTED EARNINGS PER SHARE ABOUT $20.50.Q3 GAAP EARNINGS PER SHARE $11.84.Q3 ADJUSTED EARNINGS PER SHARE $4.83.REVISES FY 2021 EPS GUIDANCE TO APPROXIMATELY $23.67 ON A GAAP BASIS.CONFIRMING $21.50 AS BASELINE FOR 2022 ADJUSTED EPS GROWTH.UPDATES FY 2021 EXPECTED INDIVIDUAL MEDICARE ADVANTAGE MEMBERSHIP GROWTH TO 450,000 MEMBERS.FY2021 EARNINGS PER SHARE VIEW $21.53 -- REFINITIV IBES DATA.QTRLY REVENUES - GAAP $20,697 MILLION VERSUS $20,075 MILLION.Q3 EARNINGS PER SHARE VIEW $4.66, REVENUE VIEW $20.91 BILLION -- REFINITIV IBES DATA.QTRLY REVENUES - ADJUSTED $20,871 MILLION VERSUS $18,823 MILLION.DURING 3Q21 COVID COSTS WERE HIGHER THAN PREVIOUSLY EXPECTED.UPDATING ITS FY 2021 EPS GUIDANCE TO TAKE A MORE CONSERVATIVE POSTURE GOING INTO FINAL MONTHS OF 2021.ANTICIPATING TOTAL MEDICARE ADVANTAGE UTILIZATION, NET OF COVID COSTS, WILL RUN APPROXIMATELY 1 PERCENT BELOW BASELINE IN Q4.QTRLY CONSOLIDATED BENEFITS EXPENSE RATIO - GAAP 87.1% VERSUS 82.6%.

Prophecy International Agrees To Provide eMite To Humana

Oct 7 (Reuters) - Prophecy International Holdings Ltd PRO.AX.N::AGREES TO PROVIDE EMITE TO HUMANA FOR INITIAL TERM OF 3 YEARS, WITH MINIMUM COMMITMENT OF AUD$1.784M MILLION IN ARR.PROVIDE EMITE FOR TOTAL CONTRACT VALUE OF AUD$5.518 MILLION OVER INITIAL TERM.

Humana Inc Intends To Maintain FY 2021 NON-GAAP EPS GUIDANCE OF $21.25 TO $21.75

Sept 7 (Reuters) - Humana Inc <HUM.N>::DURING MEETING WITH INVESTORS & ANALYSTS, CO INTENDS TO MAINTAIN ITS FY 2021 GAAP EPS GUIDANCE RANGE OF $24.97 TO $25.47.HUMANA - DURING MEETING WITH INVESTORS & ANALYSTS, CO INTENDS TO MAINTAIN ITS FY 2021 NON-GAAP EPS GUIDANCE OF $21.25 TO $21.75.HUMANA - SEEN NON-INPATIENT UTILIZATION DECLINE IN RESPONSE TO PRIOR COVID SURGES, EXPECT WILL EXPERIENCE COMPARABLE DECLINE WITH RECENT COVID INCREASE.HUMANA - FY 2021 ADJUSTED. EPS GUIDANCE CURRENTLY ASSUMES EXPECTED REDUCTIONS IN NON-COVID UTILIZATION WILL FOLLOW SIMILAR TRENDS SEEN DURING PRIOR SURGES.FY 2021 ADJUSTED. EPS GUIDANCE ASSUMES Q3, Q4 NON-COVID UTILIZATION RUNNING LOWER THAN PREVIOUSLY DISCLOSED 2.5% BELOW BASELINE EXPECTATION.FY2021 EARNINGS PER SHARE VIEW $21.55 -- REFINITIV IBES DATA.

Humana Prices $3.0 Billion Debt Offering

July 29 (Reuters) - Humana Inc <HUM.N>::HUMANA PRICES $3.0 BILLION DEBT OFFERING.PRICES SENIOR NOTES COMPRISED OF $1,500 MILLION OF COMPANY'S 0.650 PERCENT SENIOR NOTES, DUE 2023 AT 99.933 PERCENT OF PRINCIPAL AMOUNT.SENIOR NOTES SENIOR NOTES COMPRISE OF $750 MILLION OF CO'S 1.350% SENIOR NOTES, DUE 2027 AT 99.905% OF PRINCIPAL AMOUNT.PRICES $750 MILLION OF COMPANY'S 2.150 PERCENT SENIOR NOTES, DUE 2032 AT 99.804 PERCENT OF PRINCIPAL AMOUNT.EXPECTS NET PROCEEDS FROM SENIOR NOTES OFFERINGS WILL BE APPROXIMATELY $2.973 BILLION.INTENDS TO USE NET PROCEEDS FROM SENIOR NOTES OFFERINGS TO FUND ABOUT $5.7 BILLION PURCHASE PRICE OF ACQUISITION OF KINDRED AT HOME.

Humana Reports Second Quarter 2021 Financial Results Maintains Full Year 2021 Adjusted EPS Financial Guidance

July 28 (Reuters) - Humana Inc <HUM.N>::HUMANA REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS; MAINTAINS FULL YEAR 2021 ADJUSTED EPS FINANCIAL GUIDANCE.SEES FY ADJUSTED EARNINGS PER SHARE $21.25 TO $21.75.REPORTS 2Q21 EARNINGS PER DILUTED COMMON SHARE OF $4.55 ON A GAAP BASIS, $6.89 ON AN ADJUSTED BASIS.REAFFIRMS FY 2021 EXPECTED INDIVIDUAL MEDICARE ADVANTAGE MEMBERSHIP GROWTH RANGE OF APPROXIMATELY 425,000 TO 475,000 MEMBERS.GAAP CONSOLIDATED REVENUES FOR QUARTER WERE $20,645 MILLION VERSUS $19,083 MILLION.ADJUSTED CONSOLIDATED REVENUES FOR QUARTER WERE $20,582 MILLION VERSUS $19,083 MILLION.MAINTAINS FY 2021 EPS GUIDANCE OF $21.25 TO $21.75 ON ADJUSTED BASIS.REAFFIRMS FY 2021 EXPECTED INDIVIDUAL MEDICARE ADVANTAGE MEMBERSHIP GROWTH RANGE OF APPROXIMATELY 425,000 TO 475,000 MEMBERS.QTRLY GAAP CONSOLIDATED BENEFIT EXPENSE RATIO OF 85.8% VERSUS 76.4%.EXPECTS TO RECORD A MARK TO MARKET GAIN, CURRENTLY EXPECTED TO APPROXIMATE $1 BILLION, ON ITS EXISTING 40% OWNERSHIP OF KINDRED AT HOME IN Q3.UPDATES FY 2021 EPS GUIDANCE TO A RANGE OF $24.97 TO $25.47 ON A GAAP BASIS.COMPANY’S FY ADJUSTED EPS GUIDANCE ASSUMES $600 MILLION COVID RELATED HEADWIND EXPECTED TO BE LARGELY OFFSET BY FAVORABLE OPERATING ITEMS.Q2 EARNINGS PER SHARE VIEW $6.82, REVENUE VIEW $20.52 BILLION -- REFINITIV IBES DATA.FY2021 EARNINGS PER SHARE VIEW $21.70 -- REFINITIV IBES DATA.

Humana Names Susan Diamond As Chief Financial Officer

June 28 (Reuters) - Humana Inc <HUM.N>::HUMANA NAMES SUSAN DIAMOND AS CHIEF FINANCIAL OFFICER.HUMANA INC - SUSAN DIAMOND TRANSITIONED TO PERMANENT ROLE OF CHIEF FINANCIAL OFFICER, EFFECTIVE IMMEDIATELY.

Humana Announces Agreement To Acquire Onehome

Humana Inc <HUM.N>::HUMANA ANNOUNCES AGREEMENT TO ACQUIRE ONEHOME.HUMANA INC - FINANCIAL TERMS WERE NOT DISCLOSED.HUMANA INC - COMPANY DOES NOT ANTICIPATE A MATERIAL IMPACT TO 2021 EARNINGS FROM THIS PENDING TRANSACTION.

Humana Enters Into Two Separate Revolving Credit Facilities

June 4 (Reuters) - Humana Inc <HUM.N>::HUMANA INC - ENTERED INTO FIVE-YEAR $2.5 BILLION UNSECURED REVOLVING CREDIT AGREEMENT WHICH AMENDED $2 BILLION CREDIT AGREEMENT DATED MAY 22, 2017.HUMANA INC - ENTERED INTO 364-DAY $1.5 BILLION UNSECURED REVOLVING CREDIT AGREEMENT.HUMANA INC - IN ADDITION, REVOLVING CREDIT AGREEMENTS PERMIT INCURRENCE UP TO $750 MILLION OF INCREMENTAL COMMITMENTS.HUMANA INC - ON MAY 28, 2021, CO ENTERED INTO A $500 MILLION DELAYED DRAW TERM LOAN CREDIT AGREEMENT.Further company coverage: HUM.N. ((Reuters.Briefs@thomsonreuters.com;)).

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up